Latest Breaking News On - Ante anic - Page 1 : vimarsana.com

Galvanize Therapeutics Announces First Human Use of QuickShot: A Novel Contact-Sensing, Large Area, Focal Pulsed Electric Field Mapping & Ablation Catheter

/PRNewswire/ -- Galvanize Therapeutics, Inc. today announced the first human investigational use of its large-area, focal, Pulsed Electric Field (PEF) ablation...

Argá Medtech Initiates First-in-Human Trial to Assess the Safety and Effectiveness of Coherent Sine Wave Electroporation in Patients with Atrial Fibrillation

Acute procedural success achieved in all patients using a novel pulsed field ablation (PFA) sine waveform and configurable catheter. EPALINGES, Switzerland, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Argá Medtech

Galaxy Medical Receives CE Mark for CENTAURI Pulsed Electric Field System

SAN CARLOS, Calif., Aug. 29, 2022 /PRNewswire/ -- Galaxy Medical today announced that it received the CE Mark for its CENTAURI Pulsed Electric Field (PEF)

Galaxy Medical wins CE mark for pulsed electric field system

Galaxy Medical announced today that it received CE mark approval in Europe for its Centauri pulsed electric field (PEF) system.

Galaxy Medical Releases ECLIPSE-AF Remapping Data at Stanford Biodesign Retreat and Update on System Interoperability

Galaxy Medical's ECLIPSE-AF Study 90 Day Remapping Results to be Featured at the 2021 Stanford Biodesign New Arrhythmia Technologies Retreat

Galaxy Medical ECLIPSE-AF Study to be Featured in Innovative Technology Session at EHRA 2021 Annual Scientific Meeting

Press release content from PR Newswire. The AP news staff was not involved in its creation. Galaxy Medical ECLIPSE-AF Study to be Featured in Innovative Technology Session at EHRA 2021 Annual Scientific Meeting April 22, 2021 GMT SAN CARLOS, Calif., April 22, 2021 /PRNewswire/ -- Galaxy Medical announced today that the acute results of its Europe-focused ECLIPSE-AF study will be featured during the upcoming EHRA Congress in a innovative Technology presentation on April 25th by Ante Anić, M.D., Electrophysiology Laboratory Director at University Clinical Hospital in Split, Croatia, and primary investigator of the study. The ECLIPSE-AF Trial launched in September 2020 to study the acute safety of Galaxy’s flagship CENTAURI™ System, which uses Pulsed Electric Field (PEF) technology to treat cardiac arrhythmias. PEF targets arrhythmias by delivering quick bursts of high-voltage, high-frequency energy to ablate the heart. Two major innovations are unique to the CENTAURI system: